Sean P McClellan, Karla Unger-Saldaña, Priscilla Espinosa-Tamez, Erick Suazo-Zepeda, Michael B Potter, Salim Abraham Barquet-Muñoz, Leticia Torres-Ibarra, Hector Lamadrid-Figueroa, Martín Lajous
Article in Health systems and reform, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.7field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 2 countries.
Sean P McClellanDepartment of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA.
Karla Unger-SaldañaEpidemiology Research Unit, National Institute of Cancer, Mexico City, Mexico.
Priscilla Espinosa-TamezDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
Erick Suazo-ZepedaCenter for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.
Michael B PotterDepartment of Family and Community Medicine, University of California San Francisco, San Francisco, CA, USA.
Salim Abraham Barquet-MuñozDepartment of Gynecology, National Institute of Cancer, Mexico City, Mexico.
Leticia Torres-IbarraCenter for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.
Hector Lamadrid-FigueroaDepartment of Perinatal Health, National Institute of Public Health, Cuernavaca, Mexico.
Martín LajousCenter for Research on Population Health, National Institute of Public Health, Mexico City, Mexico.
University of California, San Francisco · USInstituto Nacional de Cancerología · MXHarvard Global Health Institute · USInstituto Nacional de Salud Pública · MX
Funding
Clinical and Translational Science InstituteUL1TR001872 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COLLARD, HAROLD R, JACOBY, VANESSA · 2016 to 2025
$112.1M
Quantitative Characterization of SubMicron Aggregates for Antibody TherapeuticsR44TR000182 · NCATS · NANOIMAGING SERVICES, INC. · PI CARRAGHER, BRIDGET OLIVIA, QUISPE, JOEL DAVID · 2012 to 2013
$1.2M
Mechanisms of Disease in the Newborn Human InfantT32HD041925 · NICHD · WASHINGTON UNIVERSITY · PI COLE, FRANCIS SESSIONS · 2002 to 2006
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Cervical Cancer Treatment Gap in Mexico Under · full record | OpenQuestion